http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3052938-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2007c4f9f22adaa8f498a4e0b52449ab
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57449
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2014-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5293a144438ff8327f5c8ef10553d94a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1badc65d5257f1fd9faa8d95dfa03df4
publicationDate 2016-08-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-3052938-A1
titleOfInvention Methods and products for the diagnosis and prognosis of ovarian tumor malignancy
abstract The present invention relates to methods and products for the diagnosis and prognosis of ovarian tumor malignancy based on proCOL11A1 protein which is expressed in malignant ovarian tumors but not in non-tumoral ovarian tissue or in situor benign or borderline ovarian tumors. proCOL11A1-specific antibodies can be used for high sensitivity and specificity diagnosis of ovarian cancer as well as for differentiating malignant ovarian tumors from benign or in situ tumors, and for the prognosis of ovarian tumor malignancy and for predicting borderline tumor malignancy. The invention has application in in vitromethods for the diagnosis and prognosis of ovarian tumor malignancy.
priorityDate 2013-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2123
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410671
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410670
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60750
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399412
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395940
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396288
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396105
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396287
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60700
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID316250
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284558
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60838
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36462
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360

Total number of triples: 44.